Professional Documents
Culture Documents
ans..a
appendicitis
ans.a
pts with turner have streak ovaries[non functioning] .fsh is high [no
negative feed back]
ans..c
interstitial cystitis
is a chronic condition in which you experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild
discomfort to severe pain.
the bladder expands until it's full and then signals your brain that it's time to urinate, communicating through the pelvic
nerves. this creates the urge to urinate for most people. with interstitial cystitis, these signals get mixed up you feel the
need to urinate more often and with smaller volumes of urine than most people.
interstitial cystitis most often affects women and can have a long-lasting impact on quality of life. although there's no
treatment that reliably eliminates interstitial cystitis, medications and other therapies may offer relief.
symptoms;
the signs and symptoms of interstitial cystitis vary from person to person. if you have interstitial cystitis, your symptoms may
also vary over time, periodically flaring in response to common triggers, such as menstruation, sitting for a long time, stress,
exercise and sexual activity.
o pain in your pelvis or between the vagina and anus in women or between the scrotum and anus in men (perineum).
o frequent urination, often of small amounts, throughout the day and night. people with severe interstitial cystitis may urinate
as often as 60 times a day.
o pain or discomfort while the bladder fills and relief after urinating.
the severity of symptoms caused by interstitial cystitis often varies, and some people may experience periods during which
symptoms disappear.
although signs and symptoms of interstitial cystitis may resemble those of a chronic urinary tract infection, urine cultures are
usually free of bacteria. -however, symptoms may worsen if a person with interstitial cystitis gets a urinary tract infection.
ans..d
ans.e
ans.d
ans.d
ans..d
ans..e
hyperemesis
gravidarum ,,nausea, vomiting, electrolytes abnormalities and ketone
in urine,i.v hydration and antiemetics should be given and u/s should
be done to exclude molar pregnancy
A step-wise approach to treatment of nausea and vomiting of pregnancy is provided in the algorithm (algorithm 1). The steps
are based on evidence of efficacy and safety profiles. The goal is to reduce symptoms through changes in diet/environment and
by medication, correct consequences or complications of nausea and vomiting, and minimize the fetal effects of maternal
nausea and vomiting and its treatment.
Women should try to become aware of, and avoid, environmental triggers and foods which might provoke their nausea
and vomiting. (See 'Initial approach' above.)
Where available, we suggest pyridoxine-doxylamine succinate combination therapy for initial pharmacologic treatment of
nausea of pregnancy (Grade 2B). If this drug is not available, we suggest pyridoxine, adding doxylamine succinate if
pyridoxine alone is not effective.
If nausea and vomiting persists, we suggest adding diphenhydramine 25 to 50 mg orally every four to six hours
or meclizine 25 mg orally every six hours (Grade 2C). If symptoms do not improve, we suggest adding a dopamine
antagonist (prochlorperazine, metoclopramide) (Grade 2C).
For patients who require hospitalization because of dehydration, we suggest a serotonin antagonist (ondansetron)
(Grade 2C).
Women who are dehydrated or have electrolyte abnormalities or acid-base disturbances should receive intravenous
fluids. Thiamine supplements should be added to the intravenous solution to prevent Wernicke's encephalopathy. We
suggest a short period of gut rest during hydration, followed by reintroduction of oral intake with liquids and bland, low fat
foods. We reserve use of glucocorticoids for treatment of refractory cases after the first trimester.
(See 'Glucocorticoids' above.)
The optimal timing for initiating enteral or parenteral nutrition has not been established; the decision is based upon
clinical judgment. In general, enteral nutrition is begun in women who cannot maintain their weight because of vomiting
and despite a step-wise trial of pharmacologic interventions. (See 'Enteral and parenteral nutrition' above.)
We suggest that women of child-bearing age take a multivitamin with folic acid to help prevent nausea and vomiting
during pregnancy (Grade 2C), as well as for reducing the risk of neural tube defects. (See 'Prevention' above.)
ans.a
atelectasismost common cause of postoperative fever in first 24 hrs
Postpartum fever and infection The United States Joint Commission on Maternal Welfare defines postpartum febrile
morbidity as an oral temperature of 38.0 degrees Celsius (100.4 degrees Fahrenheit) or more on any two of the first 10
days postpartum, exclusive of the first 24 hours. The first 24 hours are excluded because low grade fever during this period
is common and often resolves spontaneously, especially after vaginal birth.
Surgical site infection Wound infection is diagnosed in 2.5 to 16 percent of patients after cesarean delivery [17], generally
four to seven days after the procedure.
Endometritis Endometritis is more common following cesarean birth than following vaginal birth. The diagnosis of
endometritis is largely based upon clinical criteria: fever; uterine tenderness; foul lochia; and leukocytosis, which develop within
five days of delivery. A temperature 100.4 F (38 C) in the absence of other causes of fever, such as pneumonia, wound
cellulitis, or urinary tract infection, is the most common sign.
Atelectasis (not causal) Atelectasis is often used as an explanation for otherwise unexplained
postoperative fever. Both atelectasis and fever occur frequently after surgery, but their concurrence is
probably coincidental rather than causal.
ans..b
q1267 yo,f,vulvar itching for two years ,o/e 1-cm white area over
labia majora
ans.e
ans.c
ans.e
administer rh immunoglobulin
All Rh(D)-negative pregnant women should undergo an antibody screen at the first prenatal visit. If the initial screen is
negative, a routine repeat screen at 28 weeks of gestation is optional.
We recommend administration of antenatal anti-D immune globulin when there is an increased risk of fetomaternal
hemorrhage (Grade 1B). Some examples include miscarriage, abortion, ectopic pregnancy, multifetal reduction,
amniocentesis, chorionic villus sampling, blunt abdominal trauma, external cephalic version, antepartum bleeding, and fetal
death. We administer 300 micrograms as soon as possible within 72 hours of the event.
Postpartum Postpartum administration of anti-D immune globulin significantly reduces the risk of maternal
alloimmunization.
alternatively: give small dose + rosette test
The rosette test [48] is a qualitative, yet sensitive, test for fetomaternal hemorrhage. We suggest performing this test as an
initial screen. A standard dose of anti-D immune globulin is given to patients with a negative test. The test is designed to
give a negative result when the amount of fetomaternal hemorrhage is small (<2 mL or 0.04 percent fetal cells) and thus will
not necessitate additional doses of anti-D immune globulin; few cases require confirmatory quantitative testing [49].
ans..d
menarche is imminent
age range breast growth pubic hair growth other changes age range testes growth penis growth pubic hair growth other changes
(years) (years)
ii 815 breast budding long downy pubic peak growth 1015 enlargement of minimal or no long downy hair, not applicable
(thelarche); hair near the labia, velocity often testes; enlargement often appearing
areolar often appearing occurs soon after pigmentation of several months
hyperplasia with with breast stage ii scrotal sac after testicular
small amount of budding or several growth; variable
breast tissue weeks or months pattern noted
later with pubarche
iii 1015 further increase in amount menarche occurs 116.5 further significant increase in not applicable
enlargement of and pigmentation in 2% of girls late enlargement enlargement, amount; curling
breast tissue and of hair in stage iii especially in
areola, with no diameter
separation of their
contours
iv 1017 separation of adult in type but menarche occurs variable: 1217 further further adult in type but development of
contours; areola not in distribution in most girls in enlargement enlargement, not in distribution axillary hair and
and nipple form stage iv, 13 especially in some facial hair
secondary mound years after diameter
above breasts thelarche
tissue
v 12.518 large breast with adult in menarche occurs 1318 adult in size adult in size adult in body hair
single contour distribution in 10% of girls in distribution continues to
stage v. (medial aspects of grow and
thighs; linea alba) muscles continue
to increase in
size for several
months to years;
20% of boys
reach peak
growth velocity
during this peri
anse
suction curettage
ans..e
uteroplacental insufficiency
ans.a
ans.c
heamatocolpos.imperforate hymen
q2120 yo,f,hirsutism
ansd
ans.a
abruptio placentae
ans.c
ans..e
tmp,smx
Continuous antimicrobial prophylaxis regimens for women with recurrent urinary tract
infection
Trimethoprim-sulfamethoxazole ,Nitrofurantoin, Cefaclor, cephalexin, Norfloxacin, Ciprofloxacin
Antimicrobial prophylaxis has been demonstrated to be highly effective in reducing the risk of recurrent UTI in women.
Prophylaxis has been advocated for women who experience two or more symptomatic UTIs within six months or three or more
over 12 months. However, the degree of discomfort experienced by the woman from these infections and concerns about
antimicrobial resistance are the most important determinant of whether antimicrobial prophylaxis should be tried.
Continuous prophylaxis, postcoital prophylaxis, and intermittent self-treatment (which is not really a prophylaxis method) have all
been demonstrated to be effective in the management of recurrent uncomplicated cystitis
ans..e
primary dysmenorrhea
ans.b
ansl
ans..b
ansc
hypoestrogenic state
Increased exposure to estrogen such as early menarche or late menopause, is a risk factor for developing breast
cancer
See table.
ansc
cervical trauma
ans.b
..50-70
early menarche
pcos[chronic anovulation]
and others
anse
ans.b
ansd
fna of cyst
ans.a
reassurance.midcycle pain
ans.e
neisseria gonorrhoeae[gram negative dipploccoci within
polymorphonuclear leukocytes]
ans H..pregnancy
ansa
ans..e
ans..a
Q41painful vesicles
ans..e
painful vesicles second attack..herpes simplex normal course
to disappear within one week
ans..c
ans.c
gastroschisis
ans.e
ans.e
ans.d
ans..a
ans..a
ans.f
ans..k
normal pregnancy